Yoshiaki Wakumoto

Hypoxia-Inducible Protein 2 ( <i>HIG2</i> ), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy

Akira Togashi, Toyomasa Katagiri, Shingo Ashida et al. · Cancer Research · 2005 · 95 citations

Medicine, Molecular Biology, Oncology +17

Phase I Study of Autologous Tumor Vaccines Transduced with the GM-CSF Gene in Four Patients with Stage IV Renal Cell Cancer in Japan: Clinical and Immunological Findings

Kenzaburo Tani, Miyuki Azuma, Yukoh Nakazaki et al. · Molecular Therapy · 2004 · 87 citations · Full text

Medicine, Immunology, Oncology +17

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up

Yoshihiko Tomita, Tsunenori Kondo, Go Kimura et al. · Japanese Journal of Clinical Oncology · 2019 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy

Kosuke Kitamura, Toshiyuki China, Mayuko Kanayama et al. · Prostate International · 2018 · 37 citations · Full text

Medicine, Surgery, Urology +17

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Takeshi Ieda, Satoru Muto, Fumitaka Shimizu et al. · EBioMedicine · 2016 · 25 citations · Full text

Medicine, Oncology, Urology +10